Another CRISPR approval not likely ‘any time soon’ – report (NASDAQ:CRSP)
Bill Oxford/iStock via Getty Images Following the recent FDA green light for the gene therapy Casgevy, "it is unlikely" that ...
Wednesday, May 7, 2025
Tag: NASDAQCRSP
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.